Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Bots

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 5, 2015
HDAC1 and HDAC2 collectively regulate intestinal stem cell homeostasisCheryl D Zimberlin, Cesare Lancini, Rachel Sno, et al.
Cancer Research|March 15, 2011
Deciphering the molecular events necessary for synergistic tumor cell apoptosis mediated by the histone deacetylase inhibitor vorinostat and the BH3 mimetic ABT-737Adrian P Wiegmans, Amber E Alsop, Michael Bots, et al.
Molecular Cell|October 25, 2011
Granzyme B-dependent proteolysis acts as a switch to enhance the proinflammatory activity of IL-1αInna S Afonina, Graham A Tynan, Susan E Logue, et al.
Blood|January 14, 2014
Differentiation therapy for the treatment of t(8;21) acute myeloid leukemia using histone deacetylase inhibitorsMichael Bots, Inge Verbrugge, Benjamin P Martin, et al.
Blood|August 31, 2012
NKT cell adjuvant-based tumor vaccine for treatment of myc oncogene-driven mouse B-cell lymphomaStephen R Mattarollo, Alison C West, Kim Steegh, et al.
Blood|September 30, 2004
SPI-CI and SPI-6 cooperate in the protection from effector cell-mediated cytotoxicityMichael Bots, Ingrid G M Kolfschoten, Sandra A Bres, et al.
Cancer Discovery|December 18, 2012
The mTORC1 inhibitor everolimus prevents and treats Eμ-Myc lymphoma by restoring oncogene-induced senescenceMeaghan Wall, Gretchen Poortinga, Kym L Stanley, et al.
Molecular Cancer Therapeutics|October 5, 2013
Molecular and biologic analysis of histone deacetylase inhibitors with diverse specificitiesAndrea Newbold, Geoffrey M Matthews, Michael Bots, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2010
Asymmetric cell division of T cells upon antigen presentation uses multiple conserved mechanismsJane Oliaro, Vanessa Van Ham, Faruk Sacirbegovic, et al.
Cancer Discovery|March 21, 2022
Epigenetic Activation of Plasmacytoid DCs Drives IFNAR-Dependent Therapeutic Differentiation of AMLJessica M Salmon, Izabela Todorovski, Kym L Stanley, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 5, 2015
HDAC1 and HDAC2 collectively regulate intestinal stem cell homeostasisCheryl D Zimberlin, Cesare Lancini, Rachel Sno, et al.
Cancer Research|March 15, 2011
Deciphering the molecular events necessary for synergistic tumor cell apoptosis mediated by the histone deacetylase inhibitor vorinostat and the BH3 mimetic ABT-737Adrian P Wiegmans, Amber E Alsop, Michael Bots, et al.
Molecular Cell|October 25, 2011
Granzyme B-dependent proteolysis acts as a switch to enhance the proinflammatory activity of IL-1αInna S Afonina, Graham A Tynan, Susan E Logue, et al.
Blood|January 14, 2014
Differentiation therapy for the treatment of t(8;21) acute myeloid leukemia using histone deacetylase inhibitorsMichael Bots, Inge Verbrugge, Benjamin P Martin, et al.
Blood|August 31, 2012
NKT cell adjuvant-based tumor vaccine for treatment of myc oncogene-driven mouse B-cell lymphomaStephen R Mattarollo, Alison C West, Kim Steegh, et al.
Blood|September 30, 2004
SPI-CI and SPI-6 cooperate in the protection from effector cell-mediated cytotoxicityMichael Bots, Ingrid G M Kolfschoten, Sandra A Bres, et al.
Cancer Discovery|December 18, 2012
The mTORC1 inhibitor everolimus prevents and treats Eμ-Myc lymphoma by restoring oncogene-induced senescenceMeaghan Wall, Gretchen Poortinga, Kym L Stanley, et al.
Molecular Cancer Therapeutics|October 5, 2013
Molecular and biologic analysis of histone deacetylase inhibitors with diverse specificitiesAndrea Newbold, Geoffrey M Matthews, Michael Bots, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2010
Asymmetric cell division of T cells upon antigen presentation uses multiple conserved mechanismsJane Oliaro, Vanessa Van Ham, Faruk Sacirbegovic, et al.
Cancer Discovery|March 21, 2022
Epigenetic Activation of Plasmacytoid DCs Drives IFNAR-Dependent Therapeutic Differentiation of AMLJessica M Salmon, Izabela Todorovski, Kym L Stanley, et al.
Pageof 3